A Feasibility Study to Collect Data in Patients With Haemophilia
Completed
- Conditions
- Hemophilia
- Interventions
- Other: Laboratory variables
- Registration Number
- NCT00798499
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to collect reference data in patients with haemophilia. The study will also collect and store blood samples for potential future exploratory research in the disease area.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
- Provision of written informed consent
- Patients with haemophilia, all severities
- At least 18 years old.
Exclusion Criteria
- No exclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Laboratory variables Laboratory variables
- Primary Outcome Measures
Name Time Method Laboratory variables related to coagulation, SAEs in connection to blood sampling procedures will be collected, non-serious AEs will not be recorded The variables will be measured at first visit.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇸🇪Stockholm, Sweden